Microbix Biosystems Inc. has seen a notable uptick in its stock price, closing up 3.70% in the last trading session.
Microbix Biosystems Inc. (MBX.TO) experienced a positive trading day, with its stock rising to CA$0.28, reflecting a 3.70% increase. This upward movement comes amidst ongoing developments in the biotech sector, which may be contributing to investor optimism.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$41.25M
52W high
$0.34
52W low
$0.21
1W change
+0.00%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX
Wall Street analysts forecast MBX stock price to rise 29.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+29.0% Upside
Current Price
C$0.31
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
48.0%
Annualized
90-Day Vol
51.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.37
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.33 | C$0.28 โ C$0.39 |
| 60 trading days | C$0.35 | C$0.28 โ C$0.44 |
| 90 trading days | C$0.37 | C$0.28 โ C$0.49 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors in Microbix Biosystems should consider the potential for growth as the company continues to report incremental revenue increases, despite its current net loss.
Microbix Biosystems Inc. sees stock rise 3.70% in one day.
The market cap of Microbix has reached CA$37.1 million, indicating a modest valuation in the biotech sector.
Bull case
The recent rise in Microbix's stock price might indicate renewed investor confidence. As the company prepares to release its Q2 fiscal 2026 results, thereโs hope that these results will show further revenue growth, building on the 13% increase reported in Q1 2026.
Bear case
Despite the positive movement, Microbix still faces challenges. The company has a negative profit margin and a history of net losses, which could dampen long-term investor enthusiasm.
Recent Performance Overview
In the last trading session, Microbix Biosystems Inc. saw its stock price increase by 3.70%, closing at CA$0.28. This uptick is significant for investors who have been monitoring the company's performance closely, especially in light of its recent revenue reports.
Future Prospects
Looking ahead, Microbix is scheduled to release its Q2 fiscal 2026 results on May 14, 2026. Investors are hopeful that these results will demonstrate continued revenue growth, building on the 13% increase reported in Q1 2026. For more insights on Microbix's financial performance, check out our detailed analysis on MBX.TO.
Market Sentiment
The biotech sector has been a focal point for investors, and Microbix's recent stock performance reflects a broader trend of optimism in the industry. However, potential investors should weigh the company's current challenges, including its negative profit margin, against its growth potential. For further details, visit our page on Microbix Biosystems.
Advertisement
